Of note, EGFR downregulation, because of the internalization and subsequent degradation of EGFR in lysosomes, has recently been reported to be an important determinant of the efficacy of cetuximab treatment for colorectal cancer (33). This evidence concerns the gene EGFR and colorectal cancer.